Liverpool Centre for Cardiovascular Science
Tackling high levels of cardiac disease and helping people live longer, healthier lives
Tackling high levels of cardiac disease and helping people live longer, healthier lives
Professor Gregory Lip discusses the effective Atrial Fibrillation Better Care Pathway (ABC) and how it can be utilised to detect and recude the risk of cardiac illness
This cross-cutting, dynamic theme brings together colleagues in basic science and clinical medicine.
It promotes the integration of a full range of expertise from laboratory to clinical research, allowing the translational aspects of cardiovascular medicine to be fully realised. In addition, we have strengths in precision medicine, with insights from proteomics and genomics, as well as the discovery of novel biomarkers.
The latter would aid insights into pathophysiology and risk stratification, and provide surrogate markers of clinical outcomes when testing early interventions.
We systematically extract and analyse large data sets from epidemiological studies to answer important health questions.
This approach will enable us to identify trends, risk factors, and outcomes in cardiovascular medicine, from which the information obtained may be used to support healthcare initiatives and patient education.
We will be able to provide a global overview by utilising data sets from the UK, and our existing collaborators and academic links in other parts of the world such as the United States, Denmark, Korea, China, Taiwan and Japan.
We are committed to developing new personalised treatments and pathways that can be utilised in treating cardiovascular disease and similar conditions. This is aimed at improving patient outcomes, and bridging the gap between primary, secondary and tertiary care systems.
At the LCCS, the focus is on patient-centred research, with qualitative approaches to help understand patient values and preferences. We hope that our results will be applicable to a range of individuals including nurses and allied healthcare professionals. It may be used to support clinical treatments and counselling interventions to improve outcomes and patient satisfaction.
This area of research is targeted at identifying risk factors that may have an impact on incident cardiovascular diseases. These have led to the development of impact modelling and public health initiatives, including addressing cardiovascular inequalities.
Our interests within applied health have included health economics, modelling, and outcomes research to investigate the impact on health services in the UK and globally.